MIC-1, a secretory protein that is strongly upregulated by activated p53, can be detected in the blood of mice bearing human tumor xenografts after treatment with doxorubicin, a genotoxic p53 activator of the MDM2 antagonist nutlin-3. Here, TP53 is linked to neoplasm.